Type 2 diabetes (DM2) is a syndrome characterized by postprandial hyperglycemia normally due to peripheral resistance to insulin and accounts for approximately 90% of diabetes cases worldwide and it is usually related to dyslipidemia, overweight/obesity and physical inactivity and increase in the risk of cardiovascular disease. This study aimed to compare the metabolic and inflammatory profile of hyperglycemic with non-hyperglycemic subjects in a group of patients undergoing coronary arteriography. Our group of patients showed that 63.16% presented glycaemia above 99 mg/dL (from the hyperglycemic patients, 31 individuals were classified as glucose intolerant and 29 as diabetic). Significant differences were found for glycaemia, LDL-c (Low Density Lipoprotein), and hs-CRP (high sensitivity C reactive protein) levels. Nevertheless it is possible to observe that patients with higher glycaemia showed increased values of Total Cholesterol, Triglycerides, LDL-c, Castelli Index I and II and estimative of LDL-c size particle and decreased HDL-c (High Density Lipoprotein) values. The comparison between hs-CRP levels and biochemical parameters shows significant differences for Body Mass Index, Triglycerides, HDL-c and the estimative of LDL-c particle. Also, the presence of Metabolic Syndrome is more prevalent in patients with high levels of hs-CRP. Diabetes patients have more significant increase in morbidity and mortality than the general population frequently due to further complications associated with the resistance to insulin. It is indispensable to outline the anthropometric and biochemical profile from hyperglycemic patients in order to work on secondary prevention of cardiovascular disease.
Lundh, M., Scully, S.S., Mandrup-Poulsen, T. and Wagner, B.K. (2013) Small-Molecule Inhibition of Inflammatory Beta-Cell Death. Diabetes, Obesity & Metabolism, 15, 176-184. http://dx.doi.org/10.1111/dom.12158
Donath, M.Y., Schumann, D.M., Faulenbach, M., Ellingsgaard, H., Perren, A. and Ehses, J.A. (2008) Islet Inflammation in Type 2 Diabetes: From Metabolic Stress to Therapy. Diabetes Care, 31, S161-S164. http://dx.doi.org/10.2337/dc08-s243
Abdulreda, M.H. and Berggren, P.O. (2013) Islet Inflammation in Plain Sight. Diabetes, Obesity & Metabolism, 15, 105-116. http://dx.doi.org/10.1111/dom.12160
Jain, D., Weber, G., Eberhard, D., Mehana, A.E., Eglinger, J., Welters, A., Bartosinska, B., Jeruschke, K., Weiss, J., Path, G., Ariga, H., Seufert, J. and Lammert, E. (2015) DJ-1 Protects Pancreatic Beta Cells from Cytokine- and Streptozotocin-Mediated Cell Death. PLoS One, 10, e0138535. http://dx.doi.org/10.1371/journal.pone.0138535
Molena-Fernandes, C., Bersani-Amado, C.A., Ferraro, Z.M., Hintze, L.J., Nardo Jr., N. and Cuman, R.K. (2015) Effects of Exercise and Metformin on the Prevention of Glucose Intolerance: A Comparative Study. Brazilian Journal of Medical and Biological Research, 48, 1101-1108. (Epub Ahead of Print)
Dongway, A.C., Faggad, A.S., Zaki, H.Y. and Abdalla, B.E. (2015) C-Reactive Protein Is Associated with Low-Density Lipoprotein Cholesterol and Obesity in Type 2 Diabetic Sudanese. Diabetes, Obesity & Metabolism: Targets and Therapy, 8, 427-435.
Luijks, H., Biermans, M., Bor, H., van Weel, C., Lagro-Janssen, T., de Grauw, W. and Schermer, T. (2015) The Effect of Comorbidity on Glycemic Control and Systolic Blood Pressure in Type 2 Diabetes: A Cohort Study with 5 Year Follow-Up in Primary Care. PLoS One, 10, e0138662. http://dx.doi.org/10.1371/journal.pone.0138662
Zethelius, B. and Cederholm, J. (2015) Comparison between Indexes of Insulin Resistance for Risk Prediction of Cardiovascular Diseases or Development of Diabetes. Diabetes Research and Clinical Practice, 110, 183-192.
Liang, K.W., Lee, W., Lee, W.L., Liao, Y.C., Wang, K.Y., Lee, I.T., Wang, J.S. and Sheu, W.H. (2015) Circulating Adipokines and Insulin Resistance in Subjects with Combined Cardiac and Metabolic Syndrome X. Diabetology & Metabolic Syndrome, 7, 83. http://dx.doi.org/10.1186/s13098-015-0078-4
Alie, N., Eldib, M., Fayad, Z.A. and Mani, V. (2015) Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation. Clinical Medicine Insights: Cardiology, 8, 13-21.
Schmidt, F.M., Weschenfelder, J. and Sander, C. (2015) Inflammatory Cytokines in General and Central Obesity and Modulating Effects of Physical Activity. PLoS ONE, 10, e0121971. http://dx.doi.org/10.1371/journal.pone.0121971
Contreras-Rodríguez, A., Gómez-Díaz, R.A., Tanus-Hajj, J., Talavera, J.O., Mondragón-González, R. and Wacher, N.H. (2015) Carotid Intima-Media Thickness, Ankle-Arm Index, and Inflammation Profile in Mexican Patients with Early and Late Onset Type 2 Diabetes. Revista de Investigación Clínica, 67, 240-249.
Kawada, T., Otsuka, T., Inagaki, H., Wakayama, Y. and Katsumata, M. (2015) Biological Markers, Lifestyles and Metabolic Syndrome in Workers. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 9, 71-73. http://dx.doi.org/10.1016/j.dsx.2015.02.009
Coffman, E. and Richmond-Bryant, J. (2015) Multiple Biomarker Models for Improved Risk Estimation of Specific Cardiovascular Diseases Related to Metabolic Syndrome: A Cross-Sectional Study. Population Health Metrics, 13, 7. http://dx.doi.org/10.1186/s12963-015-0041-5
Lloyd-Jones, D.M., Hong, Y. and Labarthe, D. (2010) American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal through 2020 and beyond. Circulation, 121, 586-613. http://dx.doi.org/10.1161/CIRCULATIONAHA.109.192703
Tanimoto, M., Kanazawa, A., Hirose, T., Yoshihara, T., Kobayashi-Kimura, S., Nakanishi, R., Tosaka, Y., Sasaki-Omote, R., Kudo-Fujimaki, K., Komiya, K., Ikeda, F., Someya, Y., Mita, T., Fujitani, Y. and Watada, H. (2015) Comparison of Sitagliptin with Nateglinide on Postprandial Glucose and Related Hormones in Drug-Naive Japanese Patients with Type 2 Diabetes Mellitus: A Pilot Study. Journal of Diabetes Investigation, 6, 560-566. http://dx.doi.org/10.1111/jdi.12338
Barrot-de la Puente, J., Mata-Cases, M., Franch-Nadal, J., Mundet-Tudurí, X., Casellas, A., Fernandez-Real, J.M. and Mauricio, D. (2015) Older Type 2 Diabetic Patients Are More Likely to Achieve Glycaemic and Cardiovascular Risk Factors Targets than Younger Patients: Analysis of a Primary Care Database. International Journal of Clinical Practice, 69, 1486-1495. http://dx.doi.org/10.1111/ijcp.12741
Du, H., Dong, C.Y. and Lin, Q.Y. (2015) Risk Factors of Acute Myocardial Infarction in Middle-Aged and Adolescent People ( http://dx.doi.org/10.1186/s12872-015-0102-5
Roca-Rodríguez, M.D., Tapia-Guerrero, M.J., Maraver-Selfa, S., Tinahones, F.J. and Mancha-Doblas, I. (2015) Lixisenatide Clinical Experience on Patients with Type 2 Diabetes Andobesity in Endocrinology Offices in Malaga. Endocrinología y Nutrición, 62, 512-514. http://dx.doi.org/10.1016/j.endonu.2015.07.004
Galhardo, J. and Shield, J. (2015) The Role of Haemoglobin A1c in Screening Obese Children and Adolescents for Glucose Intolerance and Type 2 Diabetes. Acta Medica Portuguesa, 28, 307-315.
Lopategi, A., López-Vicario, C., Alcaraz-Quiles, J., García-Alonso, V., Rius, B., Titos, E. and Clària, J. (2015) Role of Bioactive Lipid Mediators in Obese Adipose Tissue Inflammation and Endocrine Dysfunction. Molecular and Cellular Endocrinology, 419, 44-59. http://dx.doi.org/10.1016/j.mce.2015.09.033
Sun, M., Zhang, L., Chen, A., Liu, X., Shao, X. and Zou, H. (2015) Association of C-Reactive Protein and Metabolic Disorder in a Chinese Population. International Journal of Environmental Research and Public Health, 12, 8228-8242. http://dx.doi.org/10.3390/ijerph120708228
Nowotny, K., Jung, T., Hohn, A., Weber, D. and Grune, T. (2015) Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus. Biomolecules, 5, 194-222. http://dx.doi.org/10.3390/biom5010194
Schuster, D.P. (2010) Obesity and the Development of Type 2 Diabetes: The Effects of Fatty Tissue Inflammation. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 3, 253-262. http://dx.doi.org/10.2147/dmsott.s7354
Vargas, R., Ryder, E., Diez-Ewald, M., Mosquera, J., Durán, A., Valero, N., Pedreanez, A., Pena, C. and Fernández, E. (2015) Increased C-Reactive Protein and Decreased Interleukin-2 Content in Serum from Obese Individuals with or without Insulin Resistance: Associations with Leukocyte Count and Insulin and Adiponectin Content. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. [Epub ahead of print] http://dx.doi.org/10.1016/j.dsx.2015.09.007
Slagter, S.N., van Vliet-Ostaptchouk, J.V., van Beek, A.P., Keers, J.C., Lutgers, H.L., van der Klauw, M.M. and Wolffenbuttel, B.H. (2015) Health-Related Quality of Life in Relation to Obesity Grade, Type 2 Diabetes, Metabolic Syndrome and Inflammation. PLoS ONE, 10, e0140599. http://dx.doi.org/10.1371/journal.pone.0140599
Liu, Y., Luo, B., Shi, R., Wang, J., Liu, Z., Liu, W., Wang, S. and Zhang, Z. (2015) Nonerythropoietic Erythropoietin-Derived Peptide Suppresses Adipogenesis, Inflammation, Obesity and Insulin Resistance. Scientific Reports, 5, 15134. http://dx.doi.org/10.1038/srep15134
Li, S., Zhang, Y., Guo, Y.L., Zhu, C.G., Wu, N.Q., Qing, P., Gao, Y., Sun, J., Liu, G., Dong, Q. and Li, J.J. (2015) Effect of Glycemic and Lipid Achievements on Clinical Outcomes Type 2 Diabetic, Chinese Patients with Stable Coronary Artery Disease. Journal of Diabetes and Its Complications, 30, 115-120. http://dx.doi.org/10.1016/j.jdiacomp.2015.09.016
Zeb, I. and Budoff, M. (2015) Coronary Artery Calcium Screening: Does It Perform Better than Other Cardiovascular Risk Stratification Tools? International Journal of Molecular Sciences, 16, 6606-6620. http://dx.doi.org/10.3390/ijms16036606
Maruyama, C., Imamura, K. and Teramoto, T. (2003) Assessment of LDL Particle Size by Triglyceride/HDL-Cholesterol Ratio in Non-Diabetic, Healthy Subjects without Prominent Hyperlipidemia. Journal of Atherosclerosis and Thrombosis, 10, 186-191. http://dx.doi.org/10.5551/jat.10.186
Vargas, H.O., Nunes, S.O. and Barbosa, D.S. (2014) Castelli Risk Indexes 1 and 2 Are Higher in Major Depression but Other Characteristics of the Metabolic Syndrome Are Not Specific to Mood Disorders. Life Sciences, 102, 65-71. http://dx.doi.org/10.1016/j.lfs.2014.02.033
Vieira, E.A., Carvalho, W.A., Aras, R.J., Couto, F.D. and Couto, R.D. (2011) Triglyceride/HDL-C Ratio as a Cardiovascular Risk Indicator in Chronic Alcoholic Patients. Jornal Brasileiro de Patologia e Medicina Laboratorial, 47, 113-118. http://dx.doi.org/10.1590/S1676-24442011000200004
Yadav, R., Liu, Y. and Kwok, S. (2015) Effect of Extended-Release Niacin on High Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients. Journal of the American Heart Association, 4, e001508. http://dx.doi.org/10.1161/JAHA.114.001508
Mogarekar, M.R. and Kulkarni, S.K. (2015) Quality or Quantity? A Study of Small Dense Low-Density Lipoprotein Cholesterol, Paraoxonase 1 and Lipid Profile in Postmenopausal Women. Archives of Medical Research, 46, 534-538.
Manabe, Y., Morihara, R. and Matsuzono, K. (2015) Estimation of the Presence of Small Dense Lipoprotein Cholesterol in Acute Ischemic Stroke. Neurology International, 7, 5973. http://dx.doi.org/10.4081/ni.2015.5973
Valabhji, J. and Elkeles, R.S. (2003) Dyslipidemia in Type 2 Diabetes: Epidemiology and Biochemistry. British Journal of Diabetes & Vascular Disease, 3, 184-189. http://dx.doi.org/10.1177/14746514030030030501
American Diabetes Association (2011) Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 34, S62-S69. http://dx.doi.org/10.2337/dc11-s062
Chen, S.-C. and Tseng, C.-H. (2013) Dyslipidemia, Kidney Disease, and Cardiovascular Disease in Diabetic Patients. The Review of Diabetic Studies, 10, 88-100. http://dx.doi.org/10.1900/RDS.2013.10.88
Meshkani, R. and Adeli, K. (2009) Hepatic Insulin Resistance, Metabolic Syndrome and Cardiovascular Disease. Clinical Biochemistry, 42, 1331-1346. http://dx.doi.org/10.1016/j.clinbiochem.2009.05.018